The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Blocking patents on the combined therapeutics as described would sure corner the market and play to the longer term interests of the big pharma medical cannabis trials partnerships anticipated by APOL in the "near future" (CEO '21 review).
Data from: Bloomberg....................
Aion Therapeutic
Organization
Aion Therapeutic Inc. operates as a pharmaceutical company. The Company focuses on creating novel patent protected therapeutic formulations using medical cannabis for the treatment of patients with many types of illnesses including cancer, psychiatric disorders, addiction, viral infections, obesity, and chronic inflammation. Aio…
Founded: 13 Jan 2011
CEO: J Graham Simmonds
Chairman: Dr Stephen D Barnhill
145 viewsJul 19, 2021
“We are pleased to announce that the ICCPI has welcomed the first cancer patients, including our first international cancer patient from the UK in December to be treated with Apollon's proprietary medical cannabis products,” said CEO Barnhill.
https://www.apollon.org.uk/news-and-media/apollon-formularies-ceo-says-it-is-an-exciting-time-to-be-in-the-medical-cannabis-business
I did read that it had a patient from UK..................
You're welcome m8......... Video for you.....................
https://www.youtube.com/watch?v=GABZieBAC78
Hi Kenny, thanks for providing the information on Aion. I feel an important revenue generation announcement cannot be far off now.
Keep the faith....at least that is what I keep telling myself.
We believe that we can build a large portfolio of blocking patents while most of the rest of the world faces legal hurdles that limit efforts in this type of research and discovery."
https://www.proactiveinvestors.com/companies/news/941952/aion-therapeutic-meet-the-team-using-artificial-intelligence-to-create-a-full-lineup-of-psychedelic-and-cannabis-therapies-941952.html
Up 25% in last month................
archie2......... Maybe for export rules law, I don't know to be honest.........................
Trading volume.......................
https://uk.finance.yahoo.com/quote/AION.CN/history?p=AION.CN
Not sure why these two (APOL & Aion) have not got together yet (merged). Similar therapeutic targets, personnel in common, shared interests in Negril
MARKET CAP $2.95 Canadian......................
Down 77.27% in last year............................
AION • CNSX
Aion Therapeutic Inc
$0.025
77.27%
-0.085 1Y
Jan 27, 11:54:39 AM UTC-5 · CAD · CNSX · Disclaimer
Adding director Kevin Sheil will step aside to pursue other interests..............
https://www.apollon.org.uk/team/kevin-sheil
https://www.proactiveinvestors.co.uk/companies/news/972335/apollon-formularies-names-dr-herbert-fritsche-as-director-972335.html
AfriAG few tweets share price tanked.
APOL loads of tweets share price tanked. IMHO DYOR........................
Rod McIllree Bluejay Mining PLC....... Down 13.15% in last year............
The growers will need paying, one of the reasons why the BOD need to start selling........ IMHO
Buys still showing as sells as they are below the mid price........
just cant go there as yet and probably never. likewise i'd take my original investment and that means 40p which shows the loss from the afriag days. if they sign shipments might start to change
If I get my original investment back in AfriAg I would be very happy. I have however continued to buy shares in Apollon as I like the story, so overall I still anticipate seeing a profit if/when the licencing agreements are signed.